Patients with T2D remission after BS have higher levels of adiponectin and lower high‐sensitivity C‐reactive protein than those without remission, and elevated adiponectin is associated with enhanced β‐cells function, greater fat loss, and lower triglyceride levels,117 which indicates that inflammation and insulin resistance may be reduced. Here, ADIPOQ is linked to type 2 diabetes mellitus.